The United Laboratories International Holdings Limited (HKG:3933)
11.96
+0.26 (2.22%)
Nov 19, 2025, 4:08 PM HKT
HKG:3933 Market Cap
HKG:3933 has a market cap or net worth of 23.6 billion as of November 19, 2025. Its market cap has increased by 16.99% in one year.
Market Cap
23.60B
Enterprise Value
19.39B
Revenue
15.45B
Ranking
n/a
PE Ratio
6.47
Stock Price
11.96
Market Cap Chart
Since June 15, 2007, HKG:3933's market cap has increased from 4.33B to 23.60B, an increase of 444.70%. That is a compound annual growth rate of 9.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 23.08B | 2.78% |
| Dec 31, 2024 | 22.46B | 76.32% |
| Dec 29, 2023 | 12.74B | 43.06% |
| Dec 30, 2022 | 8.90B | 11.62% |
| Dec 31, 2021 | 7.98B | -21.20% |
| Dec 31, 2020 | 10.12B | 8.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 313.45B |
| Hansoh Pharmaceutical Group Company | 236.23B |
| JD Health International | 214.82B |
| Innovent Biologics | 153.63B |
| WuXi Biologics | 130.96B |
| Sino Biopharmaceutical | 124.78B |
| Akeso | 102.98B |
| Sichuan Kelun-Biotech Biopharmaceutical | 99.99B |